FDA Offers Workshop On Non-Inferiority Studies Of Antibacterial Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
How to set the margins in non-inferiority studies of new antibacterial drugs is the hard question the workshop will tackle.